PF-Atlas › Clinical Trials › NCT06106789

A Study of the Clinical Benefit of Tobramycin Inhalation Solution

Tobramycin inhalation solution · Not specified

Registry ID
NCT06106789
Phase
Not specified
Status
Active, not recruiting
Drug / intervention
Tobramycin inhalation solution
Sponsor
Qianfoshan Hospital
Start
2023-04-01

About this trial

Tobramycin inhalation solution is evaluated in NCT06106789, a idiopathic pulmonary fibrosis study sponsored by Qianfoshan Hospital. Current status: Active, not recruiting.

View NCT06106789 on ClinicalTrials.gov →

Explore related

All Tobramycin inhalation solution trialsAll IPF trials

Related trials

tobramycin inhalation solution — NCT02657473
Medical disclaimer. This page summarizes public trial data for NCT06106789 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.